Role of peroxynitrite and poly (ADP-ribosyl) synthetase activation in cardiovascular derangement induced by zymosan in the rat

Life Sciences

Volumn 63, Issue 11, 1998, Pages 923-933

  Cuzzocrea, Salvatore ^b   Zingarelli, Basilia ^a   Caputi, Achille P ^c  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF MESSINA   (Italy)

^c NONE

Author keywords

Non septic shock; PARS; Peroxynitrite; Zymosan

Indexed keywords

3 AMINOBENZAMIDE; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITRATE; NITRITE; PEROXYNITRITE; ZYMOSAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; ENZYME ACTIVATION; INFLAMMATION; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; SHOCK; THORACIC AORTA; VASCULAR ENDOTHELIUM;

ANIMALS; AORTIC DISEASES; BENZAMIDES; ENZYME ACTIVATION; ENZYME INHIBITORS; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAPERITONEAL; MALE; NIACINAMIDE; NITRATES; OXIDANTS; POLY(ADP-RIBOSE) POLYMERASES; RATS; RATS, SPRAGUE-DAWLEY; SHOCK, CARDIOGENIC; TYROSINE; ZYMOSAN;

EID: 1242281654     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00350-6     Document Type: Article

References (39)

1. 1. D.D. REES, Biochem Soc Trans. 23 1025-1029 (1995).
2. 2. C. SZABÓ, New Horizons 3 3-32 (1995).
3. 3. Y.K. YOUN, C. LALONDE and R. DEMLING, Circ. Shock 35 245-249 (1991).
4. 4. J. MCCORD, New Horizons 1 70-76 (1993).
5. 5. J.P. CROW and J.S. BECKMAN, Adv Pharmacol 34 17-43 (1995).
6. 6. C. SZABÓ, Shock 6 79-88 (1996).
7. 7. B. ZINGARELLI, M. O'CONNOR, H. WONG, A.L. SALZMAN and C. SZABÓ, J Immunol 156 350-358 (1996).
8. 8. N.A. BERGER, Am. J Respir. Cell. Mol. Biol. 4 1-3 (1991).
9. 9. C.G. COCHRANE, Mol. Aspects Med. 12 137-147 (1991).
10. 10.J. ZHANG, V.L. DAWASON, T.M. DAWASON and S.H. SNYDER, Science 263 687-689 (1994).
11. 11.C. SZABÓ, B. ZINGARELLI, M. O'CONNOR and A.L. SALZMAN, Proc. Natl. Acad. Sci. USA 93 1753-1758 (1996).
12. 12.C. SZABÓ, B. ZINGARELLI and A.L. SALZMAN, Circ Res. 78 1051-1063 (1996).
13. 13.C. SZABÓ, S. CUZZOCREA, B. ZINGARELLI, M. O'CONNOR and A.L. SALZMAN, J Clin Invest 100 723-735 (1997).
14. 14.C. LUNDBERG and K.E. ARFORS, Inflammation 7 247-254 (1983).
15. 15.T.J. TEIXEIRA, P.G. WILLIAMS and P.G. HELLEWELL, Br. J. Pharmacol. 110 416-422 (1993).
16. 16.R. DEMLING, I. NAYAKMU, K.C. KEGAMI AND C. LALONDE, Shock 2 222-227 (1994).
17. 17.M.R. MAINOUS, W. ERTEL, I.H. CHAUDRY AND E.A. DEITCH, Shock 4 193-199 (1995).
18. 18.S. CUZZOCREA, B. ZINGARELLI, G. CALAPAI, F. NAVA and A.P. CAPUTI, Life Sci. 60 215-220 (1996).
19. 19.S. CUZZOCREA, A. FILIPPELLI, B. ZINGARELLI, M. FALCIANI, A.P. CAPUTI and F. ROSSI, Shock 7 351-358 (1997).
20. 20.S. CUZZOCREA, B. ZINGARELLI, L. SAUTEBIN, A. RIZZO, C. CRISAFULLI, G. M. CAMPO, G. COSTANTINO, G. CALAPAI , F. NAVA, M. DI ROSA and A.P. CAPUTI, Shock, 4 268-275 (1997).
21. 21.S. CUZZOCREA, B. ZINGARELLI, G. COSTANTINO, A. SZABÓ, A.L. SALZMAN, A.P. CAPUTI and C. SZABÓ, Br J Pharmacol 121 1065-1074 (1997)
22. 22.R.J.A. GORIS, I.P.T. VAN BEBBER, R.M.H. MOLLEN and J.P. KOOPMAN, Arch Surg 126 561-565 (1991).
23. 23.E.J.U. VON ASMUTH, I.G. MAESSEN, C.J. VAN DER LINDEN and W.A. BUURMAN, Scand J Immunol 32 313-319 (1990).
24. 24.J. DAMAS, G. REMACLE-VOLON and V. BOURDON, EUT J Pharmacol 231 231-236 (1993).
25. 25.N.S. DOHERTY, T.H. BEAVER, K.Y. CHAN, R.J. DINERSTEIN and K.A. DIEKEMA, Br. J. Pharmacol. 101 869-874 (1990).
26. 26.T.S. RAO, J.L. CURRIE, A.F. SHAFFER and P.C. ISAKSON, J. Pharmacol. Exp. Therap. 269 917-925 (1993).
27. 27.I.P.T. VAN BEBBER, K.F. BOEKHOLZ, R.J.A. GORIS, P.H.M. SCHILLINGS, H.P. BINGES, S. BAHRAMI, H. REDL and G. SCHLAG, J Surg Res 47 471-475 (1989).
28. 28.P.M. FERNANDEZ, A. HENSEN, A. OTANI and T.E HUGLI, J. Immunol. 120 109-115 (1978).
29. 29J. SNYDERMAN, J. PHILLIPS and S.E. MERGENHAGEN, Infect. Immun, 1 521-525 (1970).
30. 30.J.L. MEHTA, D.L. LAWSON, F.A. NICOLINI, M.H. ROSS and D.W. PLAYER Am J Physiol 261 H327-H334 (1991).
31. 31.T. MUROHARA, K. KUGYYAMA, S. SUGIYAMA, M. OHGUSHI and H. YASUE, J Cardiovasc Pharmacol 21 760-766 (1993).
32. 32.H. RUBBO, R. RADI, M. TRUJILLO, R. TELLERI, B. KALYANARAMAN, S. BARNES, M. KIRK and B.A. FREEMAN, J. Biol. Chem. 269 26066-26075 (1996).
33. 33.A.M. MILES, D.S. BOHLE, P.A. GLASSBRENNER, B. HANSERT, D.A. WINK and M.B. GRISHAM, J. Biol. Chem. 271 40-47 (1996).
34. 34.J.S. BECKMAN, T.W. BECKMAN, J. CHEN, P.A. MARSHALL and B.A. FREEMAN, Proc Natl Acad Sci USA 87 1620-1624 (1990).
35. 35.H. ISCHIROPOULOS, L. ZHU and J.S. BECKMAN, J. Arch. Biochem. Biophys. 2 446-453 (1992).
36. 36.L.M. VILLA, E. SALAS, V.M. DARLEY-USMAR, M.W. RADOMSKI and S. MONCADA, Proc. Natl. Acad. Sci. U.S.A. 91 12383-12387 (1994).
37. 37.S.J. ELLIOTT, Am. J. Physiol. 270 L954-61 (1996).
38. 38.C. PELLAT-SECEUNYK, J. WIETZERBIN, and J.C. DRAPIER, Biochem. J. 297 53-57 (1994)
39. 39.Z.Q. WANG, B. AUER, L. STINGL, H. BERGHAMMER, D. HAIDACHER, M. SCHWEIGER and E.F. WAGNER, Genes Develop. 9 510-520 (1995).